Successful trial results of drug to inhibit common-cancer-causing gene
Preliminary results from an ongoing Phase 1/2 human trial indicate a new drug dubbed OMO-103 can safely and effectively inhibit the function of a gene known to drive the growth of many common forms of cancer.For decades scientists have known a specific gene, called MYC, plays a crucial role in the proliferation of cancer cells. The gene is often over expressed in a variety of different tumors, so it has been any ideal hypothetical target for novel cancer treatments.But despite many attempts, MYC has earned a reputation as…